UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) April 27, 2006
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
000-50447
|
|
84-1521333 |
|
|
|
|
|
|
| (State or other jurisdiction
|
|
(Commission File
|
|
(IRS Employer |
| of incorporation)
|
|
Number)
|
|
Identification No.) |
| |
|
|
| 2525 28th Street, Boulder, Colorado
|
|
80301 |
|
|
|
|
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code 720-564-9100
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition
On April 27, 2006, Pharmion Corporation issued a press release
describing selected financial results of the Company for the quarter
ended March 31, 2006. A copy of the press release is attached as
Exhibit 99.1 and is being incorporated herein by reference.
The information incorporated by reference in Item 2.02 of this Form
8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934 (the
“Exchange Act”) or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933 or the Exchange Act,
regardless of any general incorporation language in such filing.
This report contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements include, without limitation, discussion
relative to markets for our products and trends in revenue, gross
margins and anticipated expense levels, as well as other statements
including words such as “anticipate,” “believe,” “plan,” “estimate,”
“expect” and “intend” and other similar expressions. All statements
regarding our expected financial position and operating results,
business strategy, financing plans, forecast trends relating to our
industry are forward-looking statements. These forward-looking
statements are subject to business and economic risks and
uncertainties, and our actual results of operations may differ
materially from those contained in the forward-looking statements.
Factors that could cause or contribute to such differences include,
but are not limited to, those factors set forth under “Risk Factors” in our annual report on Form 10-K
for the quarter and fiscal year ended December 31, 2005. As a result,
you should not place undue reliance on these forward-looking
statements. We undertake no obligation to revise these
forward-looking statements to reflect future events or developments.